Key Takeaways
- Arm delivered Q4 earnings of $0.60 per share versus the $0.58 consensus, with revenue reaching $1.49B against expectations of $1.47B
- Shares surged 12-13% in after-hours before reversing course to drop 5%
- AGI CPU orders topped $2 billion in just six weeks, but manufacturing capacity is locked in for only half that amount
- Production bottlenecks kept executives from boosting their revenue outlook
- The company is transitioning from a design-licensing strategy to producing proprietary AI processors, increasing capital requirements
Arm Holdings exceeded analyst projections in its fiscal fourth quarter of 2026, yet shares couldn’t maintain their momentum. Following an initial surge of up to 13% during extended trading, ARM reversed direction and tumbled more than 5% as market participants focused on manufacturing capacity challenges.
Arm Holdings plc American Depositary Shares, ARM
The chip designer posted adjusted profit of $0.60 per share alongside $1.49 billion in quarterly revenue. Wall Street consensus had projected earnings of $0.58 per share with sales of $1.47 billion.
Licensing income increased 29% from the year-ago period to reach $819 million. Royalty-based revenue advanced 11% year-over-year to $671 million.
The initial share price jump reflected the positive financial results. The subsequent decline followed commentary from company leadership.
Chief Executive Rene Haas revealed that orders for Arm’s newly introduced AGI CPU — which debuted in March — have already exceeded $2 billion just six weeks post-launch, representing more than twice the initial announcement figures. This represents significant market validation.
However, production capacity presents a challenge. Company leadership acknowledged securing sufficient wafers, memory components, and packaging materials to satisfy only the first $1 billion of existing orders. The additional $1 billion in demand remains unfulfilled while the company works to expand capacity.
Raymond James analyst Simon Leopold observed that these manufacturing limitations prevented executives from increasing their revenue projections.
Production Constraints Trigger Investor Concerns
The discrepancy between $2 billion in customer orders and $1 billion in confirmed manufacturing capacity appeared to trigger the overnight share price reversal.
Arm’s first quarter 2027 outlook projects adjusted earnings of $0.40 per share, plus or minus $0.04, with revenue of $1.26 billion, plus or minus $50 million. Analyst estimates had anticipated $1.25 billion in sales, placing guidance essentially on target.
Notwithstanding the earnings beat and robust AGI CPU order momentum, market participants seemed hesitant to overlook the operational risks surrounding supply chain execution.
Transitioning to a Capital-Heavy Strategy
Historically, Arm operated with a relatively asset-light business structure — licensing processor architectures to Apple, Qualcomm, Nvidia, and Samsung, then earning royalties on each unit shipped.
The company is now pivoting toward manufacturing its own semiconductors. The AGI CPU represents Arm’s inaugural proprietary processor targeting AI datacenter applications, necessitating procurement of cutting-edge 3nm wafers from TSMC and direct oversight of manufacturing operations.
This approach demands substantially more capital investment. Industry analysts have cautioned that elevated operational expenses could squeeze profit margins unless revenue expansion maintains sufficient pace.
Arm leadership conveyed optimism in their communication to shareholders. “The trajectory is unmistakable: customers seek Arm architecture as the foundation of AI datacenter infrastructure,” Haas and CFO Jason Child stated.
They further indicated the datacenter division is progressing toward a $15 billion revenue objective, with expectations it will evolve into Arm’s dominant business segment.
ARM stock has climbed more than 115% during 2026, establishing elevated expectations heading into the earnings report. Wall Street maintains a Strong Buy consensus rating on shares, reflecting 18 Buy recommendations, 3 Hold ratings, and 1 Sell rating issued over the prior three months.
The consensus analyst price target stands at $188.52 per share.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
